Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    GlycoMimetics Inc.

    NASDAQ: GLYC · Real-Time Price · USD
    17.18
    0.28 (1.66%)
    At close: Jun 27, 2025, 11:01 AM

    GlycoMimetics Statistics

    Share Statistics

    GlycoMimetics has 64.53M shares outstanding. The number of shares has increased by 0.08% in one year.

    Shares Outstanding

    n/a
    		 64.53M

    Shares Change (YoY)

    n/a
    		 0.08%

    Shares Change (QoQ)

    n/a
    		 0.05%

    Owned by Institutions (%)

    n/a
    		 47.07%

    Shares Floating

    n/a
    		 645.15K

    Failed to Deliver (FTD) Shares

    n/a
    		 17,520

    FTD / Avg. Volume

    n/a
    		 88.81%

    Short Selling Information

    The latest short interest is 1.71M, so 2.65% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.71M

    Short % of Shares Out

    n/a
    		 2.65%

    Short % of Float

    n/a
    		 3.21%

    Short Ratio (days to cover)

    n/a
    		 5.12

    Valuation Ratios

    The PE ratio is -0.42 and the forward PE ratio is -5.86. GlycoMimetics's PEG ratio is -0.25.

    PE Ratio

    n/a
    		 -0.42

    Forward PE

    n/a
    		 -5.86

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 117.3

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -0.52

    PEG Ratio

    n/a
    		 -0.25
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for GlycoMimetics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    Current Ratio

    n/a
    		 0

    Quick Ratio

    n/a
    		 0

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -1.77

    Debt / FCF

    n/a
    		 -2.15

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-9,469,789.5

    Employee Count

    n/a
    		 4

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -46.12% in the last 52 weeks. The beta is 1.6, so GlycoMimetics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.6

    52-Week Price Change

    n/a
    		 -46.12%

    50-Day Moving Average

    n/a
    		 21.7

    200-Day Moving Average

    n/a
    		 24.47

    Relative Strength Index (RSI)

    n/a
    		 43.25

    Average Volume (20 Days)

    n/a
    		 19,728

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -32.51M

    Net Income

    n/a
    		 -37.88M

    EBITDA

    n/a
    		 -37.84M

    EBIT

    n/a
    		 -37.88M

    Earnings Per Share (EPS)

    n/a
    		 -0.59
    Full Income Statement

    Balance Sheet

    The company has 10.72M in cash and 66.84M in debt, giving a net cash position of -56.12M.

    Cash & Cash Equivalents

    n/a
    		 10.72M

    Total Debt

    n/a
    		 66.84M

    Net Cash

    n/a
    		 -56.12M

    Retained Earnings

    n/a
    		 -494.36B

    Total Assets

    n/a
    		 5.99B

    Working Capital

    n/a
    		 3.38B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -31.1M and capital expenditures -9.97K, giving a free cash flow of -31.11M.

    Operating Cash Flow

    n/a
    		 -31.1M

    Capital Expenditures

    n/a
    		 -9.97K

    Free Cash Flow

    n/a
    		 -31.11M

    FCF Per Share

    n/a
    		 -0.48
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    GLYC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GLYC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 16, 2025. It was a backward split with a ratio of 1:100.

    Last Split Date

    n/a
    		 Jun 16, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:100

    Scores

    Altman Z-Score

    n/a
    		 -115.38

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist